The present study was aimed to establish the link between lncRNA-ANRIL and AMPK, and to test whether metformin prevents atherosclerosis through lncRNA-ANRIL/AMPK signaling. This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.